Positive association of serum levels of advanced glycation end products with thrombogenic markers in humans
Positive association of serum levels of advanced glycation end products with thrombogenic markers in humans
复制标题
DOI:
10.1016/j.metabol.2006.02.019
复制
发表时间:
2006-07-01
影响因子:
9.8
通讯作者:
Imaizumi, Tsutomu
中科院分区:
文献类型:
--
作者:
Enomoto, Mika;Adachi, Hisashi;Imaizumi, Tsutomu
Advanced glycation end products (AGEs) are elevated in diabetes. We have demonstrated that AGEs trigger thrombogenic responses in cultured cells. We investigated here whether serum AGE levels were positively correlated with thrombogenic markers in humans. Data for fasting serum AGE levels of 186 nondiabetic subjects were obtained from a general population in Japan. We measured body mass index, blood pressure, total cholesterol, low-density lipoprotein and high-density lipoprotein cholesterol, triglycerides, fasting plasma glucose, glycosylated hemoglobin A(1c), insulin, creatinine, uric acid, high-sensitive C-reactive protein, plasminogen activator inhibitor 1 (PAI-1), and fibrinogen. Uni- and multivariate analyses were applied for the determinants of serum AGE levels. The average AGE levels were 4.11 +/- 0.74 U/mL in males and 4.10 +/- 0.93 U/mL in females. In the univariate analysis, PAI-1 (P